Renal Cell Carcinoma (RCC) Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is a Renal Cell Carcinoma (RCC)?
Renal Cell Carcinoma (RCC) is kidney cancer, which starts in the cells of the kidneys filtering waste materials and excessive fluids from the blood. RCC is an adult kidney cancer.
What is the Importance of Timely Treatment?
- Improved Survival Rates: Early detection and treatment significantly improve survival chances. Tumor resection, mainly if localised, offers the best results; 5-year survival rates tend to be higher in early-stage cancers.
- Prevention of Tumor Dissemination: Treatment of RCC will heighten the prevention of cancer spreading to other organs, particularly the lungs, liver, and bones, thereby depriving them of effective management.
- Better Response to Treatment: Smaller, localised tumours usually undergo better surgery from targeted therapies and immunotherapy for a more controlled life quality.
- Reduction in Symptoms: Treatment at the right time under the right conditions can reduce symptoms such as pain, blood in urine, and swelling and improve the patient's overall quality of life.
What are the Common Symptoms of Renal Cell Carcinoma (RCC)?
- Blood in the Urine (Hematuria)
- Pain in the Back or Side
- Fatigue
- Weight Loss
- Fever
- Lump or Mass in the Abdomen
- Anemia
- Swelling
Causes and Risk Factors of Renal Cell Carcinoma (RCC)
Causes
- Genetic Mutations
Risk Factors:
- Smoking
- Obesity
- Chronic Kidney Disease
- High Blood Pressure (Hypertension):
- Family History and Genetic Syndromes
- Age and Gender
- Exposure to Chemicals
- Previous Kidney Cancer
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Renal Cell Carcinoma (RCC) in India
The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.
- Targeted Therapies: The aforementioned forms of such therapies are indicated for all patients, considering the possible therapeutic effects of medications for targeting RCC-specific genetic changes. Tumor control improves and gains better outcomes with impacts on patients, especially those with metastatic RCC.
- Immunotherapeutic Advances: These boost the immune system's fight against tumours and can be used with other therapies.
- Hermetic Surgery: Nephrectomies are increasingly being carried out with robotic technology in hospitals across the country, which reduces complications, improves standard precision, and saves time in recovery. This is done as minimally invasive as possible, resulting in small incisions, but has the potential to improve patient outcomes significantly.
- Personalised Medicine: These plans depend on genetic discovery, such as those at Tata Memorial, where genomics-informed treatment plans to identify pathways based on specific genotypes affecting an RCC tumour. Personalisation could enhance treatment effectiveness.
- Imaging the Future and Clinical Trials: Advanced imaging technologies such as PET-CT further improve the diagnosis and subsequent monitoring of RCC in India, featuring artificial intelligence. Current clinical trials involve gene therapy and combinations to increase treatment efficacy.
Renal Cell Carcinoma (RCC) Prevention Tip:
- Smoking: Smoking is a risk factor in RCC. Quitting smoking will significantly reduce the chances of a person having kidney cancer and contribute to overall well-being.
- Maintaining the Proper Weight: The increase in obesity has been related as a risk factor for RCC. It minimises the risk by maintaining a healthy weight through good nutrition and exercise.
- Manage Blood Pressure: Hypertension is a recognised risk factor for RCC. Blood pressure control through medication, proper diet, and exercise will further prevent kidney-related problems.
- Avoid Exposure to Harmful Chemicals: Limiting contact with carcinogens, such as asbestos, cadmium, and organic solvents, can further reduce the chances of having RCC.
- Regular Health Checkups: Regular health checkups, mainly in the presence of family history or other risk factors, may catch RCC in the early and more treatable stage.
Treatment options for Renal Cell Carcinoma (RCC)
The medical treatment for Renal Cell Carcinoma (RCC) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgery: Two main surgical procedures exist for renal cell carcinoma (RCC): radical nephrectomy, which means excision of the entire kidney, and partial nephrectomy, which consists of tumour excision with some conservation of kidney function. The best outcomes for localised RCC are related to surgery.
Targeted therapy : Agents that inhibit some biological pathways critical for tumour development are generally indicated when the disease is in more advanced stages or surgery has not yet been an option.
Cost Start From USD 8000 - USD 12000Explore Options
Immunotherapy : Checkpoint inhibitors enhance the immune response against the tumour cells so that they may be indicated for advanced or metastatic RCC, usually combined with targeted therapy.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation therapy: Radiation helps shrink tumours, palliate symptoms like pain, or treat other organ metastases such as bone or lung. It is not a first-line treatment but can also be employed for pain management.
Ablation and chemotherapy : Ablation therapies, such as RFA or cryoablation, may be done for small tumours as minimally invasive procedures in patients unfit for surgery; chemotherapy is not commonly used in renal cell carcinoma but may apply in certain histologic types or after other treatments have failed.
Cost Start From USD 600 - USD 700Explore Options
These are the standard diagnostic methods for diagnosing Renal Cell Carcinoma (RCC):
- Imaging Studies:
- CT Scan: Computed Tomography: The abdominal and pelvic CT scans are the most widely used imaging techniques for detecting RCC. They assess the size, location, and extent of tumour spread, resulting in detailed images of the kidneys and surrounding structures.
- MRI: MRI stands for Magnetic Resonance Imaging. This technique captures detailed images of soft tissues that do not show the required image under a CT scan. It also assesses tumour dissemination.
- Ultrasound: Abdominal ultrasound indeed serves as the initial test. It is established as a noninvasive measure and leads to the conclusion for further imaging if any mass is discovered. However, this may not differentiate benign and malignant tumours.
- PET Scan: In advanced cases of RCC, the cancer is detected as spreading into other body parts (for example, the lungs or bones). A PET scan is used in such cases. It also becomes crucial for the detection of metastases.
- Biopsy:
- Needle Biopsy: This technique may be employed where imaging shows a kidney tumour but does not confirm the diagnosis sufficiently.
- Urine and Blood Tests:
- Urinalysis: This urine test helps find blood in the urine (hematuria), the most common symptom of RCC. The presence of blood very often warrants further investigation.
- Blood Tests: Blood tests include kidney function tests (creatinine and BUN levels) to assess kidney function and reveal abnormalities that suggest cancer. Elevation of the erythrocyte sedimentation rate (ESR) or calcium levels could also indicate the presence of RCC.
MediRehab (chain of Rehab centres - part of MediGence provides comprehensive rehabilitation services designed to support patients in India. Additional services are as per the patient's requirement. These services include:
- Physical Rehabilitation: Physical therapy is vital to the patient's recovery because exercises help improve mobility, reduce joint pain, and decrease postoperative complications. Low-impact exercises can help build the patient's physical stamina, reduce energy expenditure, and improve overall recovery.
- Pain Management: Various alternative therapy strategies and the pharmaceutical route are always necessary for treating mucinous renal cell carcinoma pain. These strategies also help treat these latter manifestations of mucinous renal cell carcinoma, which always results in actively improving the patient's life.
- Lifestyle Modification: A dietitian plans a diet explicitly for the patient to maintain energy and support kidney function. It is a well-known fact that dehydration after treatment accelerates kidney functions.
- Psychological Support: Counseling, psychotherapy, and support groups are employed for addressing various mental issues, like anxiety, depression, and fear of returning to cancer. Human therapies significantly help with coping strategies in these patients.
- Occupational Therapy: Occupational therapists help patients return to activities of daily living independently by introducing modifications in the home, thereby making tasks easier. OT seeks to assist patients in working with their physical limitations following treatment.
Renal Cell Carcinoma (RCC), a targeted therapy-dependent malignancy, can block cancer growth pathways, and immunotherapies can boost the immune system's capability to fight cancer. Chemotherapy is not so much a treatment option for RCC. Therapy is determined, mainly focusing on cancer stage, rate of progression, and patient response to prior treatment.
Instantly Connect with our Specialists
Hospitals for Renal Cell Carcinoma (RCC) in India
OncoCare Cancer Centre
Amroha, India
Onco Care Cancer Hospital is one of the Top Cancer Treatment Centres in India focused on delivering the best and most affordable treatment for cancer patients with superior quality of care, and the latest treatment options. Chemotherapy, radiation, immunotherapy, and targeted treatment are among the available therapies in the hospital complemented by modern technological and equipment systems.
Both oncologists, surgeons, nursing personnel as well as other staff members, all contribute to discussions and come up with individualized treatment plans for patients. Realizing that traveling abroad for treatment is a tough decision for a family, Onco Care is dedicated to research and innovation as well as trying to deliver the best care now and in the future. Their interventions are to deliver medical and emotional needs and to give ‘a home of hope’ for every individual patient.
Batra Hospital
Delhi, India
- More than 35 years of trusted healthcare service
- Multi-specialty tertiary care with over 30 departments
- Comprehensive preventive, diagnostic, and therapeutic care under one roof
- International patient coordination team for seamless overseas care
Marengo Asia Hospitals, Gurugram
Gurgaon, India
- Marengo Asia Hospitals, Gurugram, is a 250-bed multi-speciality tertiary care hospital, formerly known as W Pratiksha Hospital.
- A major medical centre for Delhi NCR and North India, it is situated on Golf Course Extension Road, Sector 56, Gurugram.
- The hospital's NABH and NABL accreditation ensures compliance with international standards for patient care, safety, and quality.
- Provides extensive medical care in more than 21 specialities, including as women's health, neurology, orthopaedics, cardiology, and cancer.
- Advanced robotic-assisted spine surgery tools and neuro-monitoring technology are available at the Marengo Asia International Institute of Neuro & Spine (MAIINS), a Centre of Excellence in Neurosciences.
- Equipped with cutting-edge equipment, such as automated labs, sophisticated imaging, and contemporary operating rooms.
- Features specialised ICUs, NICUs, and modular OTs built for complex and minimally invasive procedures.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Renal Cell Carcinoma (RCC) Treatment?
The following are the growing reasons for India being frequented for Renal Cell Carcinoma (RCC) treatment:
- World-Class Health Services at Affordable Costs: The nation is proficient in advanced medical technologies and treatments, including high-quality care at often dissimilar cost ratios of Western countries.
- Most Qualified Professionals: Patients will find internationally trained, renowned hepatologists, surgeons, and specialists. Medical and individualised treatment options will complement the value of the care provided by the best experts in India.
- Complete Medical Services: From advanced diagnostic tools such as elastography and imaging to liver transplants, India has gone the extra mile to provide patients with cutting-edge facilities for total Renal Cell Carcinoma (RCC) treatment.
- Easy Medical Tourism: India is becoming a central international hub for medical tourism. Many accredited hospitals provide excellent service to international patients, including easy accessibility, visa assistance, and organised packages.
- Holistic Treatment: Most hospitals in India work towards a mainstream plus traditional treatment regime, including even Ayurvedic treatments, for complete liver health recovery and wellness, thus attending to emotional and physical wellness.
Frequently Asked Questions
If detected early and treated surgically, RCC is curable, whereas treatment of late or metastatic RCC is much more difficult since a cure may not always be achieved; therefore, the main goal of treatment will be disease management and improvement in quality of life.
The survival rates for RCC vary according to the stage at diagnosis. Localised RCC has a 5-year survival rate greater than 90%, while the rate drops significantly for metastatic RCC; however, therapies are improving pediatric outcomes.
There are no guaranteed ways to prevent RCC, but reducing risk factors like cessation of smoking, maintaining a healthy body weight, and controlling blood pressure may help decrease the chances of developing the disease.
Side effects of treatment strategies for RCC include surgery, immunotherapy, and targeted therapies; fatigue, nausea, skin rashes, high blood pressure, and increased susceptibility to infections are among them. Discussions with healthcare team members regarding potential side effects can facilitate effective management.
Yes, RCC can still recur even after successful treatment. Continuous monitoring with regular check-ups and imaging tests is necessary to catch any disease recurrence in its early stage so that measures can be taken accordingly.
The survival rate for RCC in India is stage-dependent at the time of diagnosis. For localised RCC, five-year survival can be very high (up to 80-90%). Survival rates, however, drop sharply for advanced or metastatic RCC. If detected and treated early, the prognosis is better.
A healthy diet during treatment for RCC is essential. Most hospitals in India provide dietary counselling for all patients to improve their health, maintain their weight, and support kidney function. Dietary recommendations often include a low-sodium, nutrient-rich diet and good hydration.
Post-treatment follow-up visits are scheduled for every 3 to 6 months for the next few years, depending on the stage of the cancer and involve regular imaging (CT scan or MRI) and blood tests for monitoring recurrence or metastasis.
Patients receiving treatment for RCC should ideally follow a healthy lifestyle, stay active, hydrate well, and refrain from smoking or excessive alcohol intake. Stress-relieving techniques and practising mindfulness will further improve well-being.
Reviewer
Dr. Mohit Agarwal
Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026